Michael Sweeting

30PUBLICATIONS
113CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Economic models and forecastingEpidemiological modellingMolecular targetsBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Sep 14, 2026
The Impact of Enrollment Strategies on the Performance of Time-To-Event Dose-Escalation Designs for Phase I Drug Combination Oncology Trials.

|Jul 16, 2026
A Simulation and Case Study to Evaluate the Extrapolation Performance of Flexible Bayesian Survival Models when Incorporating Real-World Data.

|Jun 05, 2026
CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

|Nov 13, 2025
Population Health and Health Inequality Impacts of the National Abdominal Aortic Aneurysm Screening Programme (NAAASP) in England.

Shainur Premji, Simon M Walker, James Koh

|Oct 27, 2025
Cost of treatment of metastatic non-small lung cancer in Sweden, 2011-2023.

Kun Kim, Michael Sweeting, Nils Wilking

|Jul 15, 2025
Optimal risk-assessment scheduling for primary prevention of cardiovascular disease.

Francesca Gasperoni, Christopher H Jackson, Angela M Wood

Pageof 5

Frequent Collaborators

3 joint publications

Dan Jackson

3 joint publications

Angela M Wood

2 joint publications

Emanuele Di Angelantonio

2 joint publications

Kristine Broglio